Back to results

Remote Monitoring and Management of Chemotherapy Induced Peripheral Neuropathy (REMOTE CIPN)

Objective

Determine the efficacy of symptom care at home with NP follow-up (SCH-NP) vs. usual care (UC) to reduce CIPN symptoms over a 12 week period after the completion of chemotherapy. Determine the efficacy of SCH-NP vs. UC to reduce the impact of CIPN on CIPN specific quality of life and disability. Determine the impact of SCH-NP on use of opioids and other CIPN treatments.

Protocol #

REMOTE-CIPN

Trial Phase:

Phase N/A

Principal Investigator:

Smith, Albert

Cancer Type
  • Bones and Joints
  • Breast
  • Cervix
  • Colon
  • Corpus Uteri
  • Kidney
  • Liver
  • Lung
  • Other Digestive Organ
  • Other Endocrine System
  • Other Female Genital
  • Other Male Genital
  • Ovary
  • Small Intestine
  • Soft Tissue
  • Stomach
Study Site
  • Stony Point
  • Virginia Commonwealth University

- Age >/= 18.
- Completion of taxane or platinum-based chemotherapy for cancer in the last 60 days.
- CIPN diagnosis during the recently completed chemotherapy. CIPN diagnosis will be based on the Toronto
criteria for Probable Distal Symmetric Polyneuropathy (neuropathy symptoms and signs).

Get more detailed information at ClinicalTrials.gov

  • Enrollment Status 1
  • Age Group Adult
  • Protocol Type Supportive Care
  • Research Study Team Tyler Phillips
    Email Study Contact

Click "I'm Interested" to get started. If you have questions, call our study contact.

I'm Interested
Have a question? We're here to help.

Email us or call us with your request.

Send an Email ยป (804) 628-6430
Share: